by Truveta Research | Sep 27, 2022 | Research, Research Insights
Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
by Truveta Research | Sep 15, 2022 | Research, Research Insights
COVID-19 impacted communities disproportionately [1]. Especially in the early days of the pandemic, countless reports of inequitable access to treatments and treatment pathways brought to light existing and new disparities in health outcomes [2]. Addressing health...
by Truveta staff | Aug 1, 2022 | News
Truveta’s innovative Governance model includes the outstanding health system leaders on our Board of Governors’ Committees. We spoke with Dr. Debbie Salas-Lopez, who serves on Truveta’s Ethics and Health Equity Committee. The committee provides strategic guidance...
by Truveta staff | Jul 25, 2022 | Culture
“We can learn so much from listening to people with different lived experiences.” The Americans with Disabilities Act (ADA) was signed on July 26th, 1990, to prohibit discrimination against people with disabilities across many areas, including employment,...
